Gladstone welcomes inquiries from journalists. Our media-relations staff is on hand to provide local, regional, national, and international journalists with accurate information about Gladstone’s research and our investigators’ areas of expertise. We are available to arrange interviews with Gladstone scientists and assist in developing story ideas.
As coronavirus concerns grow, Gladstone's virology experts are here to answer your questions, offer insight, provide context, and discuss the impacts of the outbreak on public health.
Gladstone virology experts are available for media interviews.
At Gladstone, we believe that basic science will be key for identifying potential drug targets and creating an effective vaccine. Both are sorely needed. Antivirals that can control coronavirus growth could have a huge impact not only on disease outcome but also on virus transmission from one person to another.
Associate Director, Communications
Direct line: 415.734.5000
16 - 30 of 150 Results
The new study paves the way toward more effective cancer immunotherapiesNews Release Cancer Genomic Immunology Marson Lab
Scientists from Gladstone and UC San Francisco systematically tested ways to improve the efficacy of therapeutic cells targeting cancerNews Release Research (Publication) Cancer Genomic Immunology
Researchers have discovered why immune treatments for allergies and asthma might not be as effective in obese mice and humansNews Release Research (Publication) Genomic Immunology Marson Lab
Gladstone researchers develop robust strategy for sifting through large-scale genetic data to better understand congenital heart problemsNews Release Research (Publication) Congenital Heart Disease Cardiovascular Disease Krogan Lab Pollard Lab Srivastava Lab Stem Cells/iPSCs
Removing one gene from developing heart cells suddenly makes them turn into brain cell precursors, making researchers rethink cellular identityNews Release Research (Publication) Cardiovascular Disease Bruneau Lab Stem Cells/iPSCs